Group | Ondansetron (n = 40) | Aprepitant (n = 40) | P-value |
---|---|---|---|
Variable | |||
Female [n (%)] | 20 (50) | 20 (50) | 0.87 |
Age [mean (SD)] | 34 (10.7) | 33 (11.7) | 0.76 |
Weight [mean (SD)] | 67 (18.1) | 68 (13.0) | 0.87 |
BMI [mean (SD)] | 23 (3.3) | 22 (3.4) | 0.76 |
Surgery duration [mean (SD)] | 3.8 (1.4) | 3.7 (1.4) | 0.87 |
ASA Physical status [n(%)] | |||
 I | 32 (80) | 31 (77) | 0.07 |
 II | 8 (20) | 9 (23) |  |
Motion sickness [n (%)] | 6 (15) | 7 (17.5) | 0.09 |
PONV history [n (%)] | 3 (7.5) | 4 (10) | 0.15 |
Non-smocking [n (%)] | 31 (77.5) | 30 (75) | 0.06 |
Amount of fentanyl (mcg) prescribed during surgery[mean (SD)] | 211 (61) | 222 (60) | 0.41 |